1. Pink Sheet

Orphans Dominate Products Seeking End-Of-Year Joy From CHMP

 
• By Maureen Kenny and Ian Schofield

Five of the nine products that could this week be recommended for EU approval have orphan designation. The final meeting this year of the European Medicines Agency’s key scientific committee, the CHMP, is under way in London.

Hurdles
Pan-EU approval is all but guaranteed for products clearing the CHMP hurdle • Source: Shutterstock

New therapies for conditions ranging from diabetes and adrenal insufficiency to ovarian cancer and multiple myeloma and a biosimilar version of Roche’s Herceptin could this week receive a recommendation for marketing across the EU.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Product Reviews

More from Pink Sheet